Webinars Overview
Peptide therapeutics offer immense potential but present complex development challenges, particularly in oral formats. This expert-led presentation explores how integrated DMPK, bioanalytical, and toxicology strategies can address barriers to absorption, stability, and safety. With a focus on practical case examples and proven approaches, it highlights how thoughtful study design and cross-functional expertise can streamline development and reduce risk from early studies through clinical advancement.
Learning Objectives:
Understand key DMPK challenges for peptide therapeutics, including absorption barriers and formulation impact.
Explore bioanalytical strategies for accurate peptide quantification, immunogenicity, and metabolite analysis.
Learn how peptide toxicology differs from small molecules and how to design effective safety studies.
Discover how integrated DMPK, bioanalysis, and toxicology approaches streamline development and reduce risk.
Gain insights from real-world case examples to support smarter study design and regulatory readiness.
Related Resources
-
Cyclic Peptides: FDA-Approved Drugs and Their Oral Bioavailability and Metabolic Stability Tactics
ArticlesMay 08,2025 -
Enhancing Permeability Through Exposed Polar Surface Area (EPSA) for Beyond Rule of Five (bRo5) Drug Candidates
ArticlesApr 10,2025 -
Unlocking Precision in Peptide Metabolite Identification for Next-Gen Drug Development
ArticlesMar 19,2025
Related Services and Platforms
Stay Connected
Keep up with the latest news and insights.